These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21119074)

  • 41. Adverse reactions to over-the-counter cough and cold products among children: the cases managed out of hospitals.
    Vassilev ZP; Chu AF; Ruck B; Adams EH; Marcus SM
    J Clin Pharm Ther; 2009 Jun; 34(3):313-8. PubMed ID: 19646077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Revised product labels for pediatric over-the-counter cough and cold medicines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1180. PubMed ID: 18971921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of Viscosity and Consumer Use on Accuracy of Oral Medication Dosing Devices.
    Elliott JP; McConaha J; Cornish N; Bunk E; Hilton L; Modany A; Bucker I
    J Pharm Technol; 2014 Aug; 30(4):111-117. PubMed ID: 34860900
    [No Abstract]   [Full Text] [Related]  

  • 44. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of self-prescribed nonprescription medications and dietary supplements among assisted living facility residents.
    Lam A; Bradley G
    J Am Pharm Assoc (2003); 2006; 46(5):574-81. PubMed ID: 17036643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anorectal drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Aug; 68(165):51167-70. PubMed ID: 12952012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Mar; 72(60):14669-74. PubMed ID: 17450664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(168):52302-5. PubMed ID: 11067736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of reading additional safety information on planned use of over-the-counter analgesics.
    McDonald DD; Amendola MG; Interlandi E; Wall K; Lewchik B; Polouse L; Pace N; Inthavong S; Li L
    Public Health Nurs; 2007; 24(3):230-8. PubMed ID: 17456124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parents' medication administration errors: role of dosing instruments and health literacy.
    Yin HS; Mendelsohn AL; Wolf MS; Parker RM; Fierman A; van Schaick L; Bazan IS; Kline MD; Dreyer BP
    Arch Pediatr Adolesc Med; 2010 Feb; 164(2):181-6. PubMed ID: 20124148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Over-the-counter medications and self-care.
    Lowe NK; Ryan-Wenger NM
    Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18861-9. PubMed ID: 12701599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.
    Wazaify M; Kennedy S; Hughes CM; McElnay JC
    J Clin Pharm Ther; 2005 Feb; 30(1):39-44. PubMed ID: 15659002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consumers appropriately self-treat based on labeling for over-the-counter hydrocortisone.
    Ellis CN; Pillitteri JL; Kyle TK; Ertischek MD; Burton SL; Shiffman S
    J Am Acad Dermatol; 2005 Jul; 53(1):41-51. PubMed ID: 15965419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unintentional ingestion of over the counter medications in children less than 5 years old.
    Chien C; Marriott JL; Ashby K; Ozanne-Smith J
    J Paediatr Child Health; 2003; 39(4):264-9. PubMed ID: 12755931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxicity of over-the-counter cough and cold medications.
    Gunn VL; Taha SH; Liebelt EL; Serwint JR
    Pediatrics; 2001 Sep; 108(3):E52. PubMed ID: 11533370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.